Column Group III-A, LP's Form 4 filing
Tenaya Therapeutics, Inc. (TNYA) · filed Mar 7, 2025
- Accession no.
- 0000950170-25-035789
- Filed
- Mar 7, 2025, 7:14 PM ET
- Trade date
- Mar 5, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market purchases total $25.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Column Group III-A, LPCIK 0001668085 | 10% Owner |
| Column Group III, LPCIK 0001668159 | 10% Owner |
| Column Group III GP, LPCIK 0001790965 | 10% Owner |
| Column Group Opportunity III, LPCIK 0001931825 | 10% Owner |
| TCG Opportunity III GP, LLCCIK 0001932445 | 10% Owner |
| Column Group Opportunity III GP, LPCIK 0001932874 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Common Stock | PPurchaseAcquired | +35,714,284 | $0.70 | +$24,999,998.8 | 49,313,559 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Common Stock | PPurchaseAcquired | +35,714,284 | – | – | 35,714,284 | Indirect | Duplicate filing |
| Mar 5, 2025 | Common Stock | PPurchaseAcquired | +17,857,142 | – | – | 17,857,142 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.